Sudo T - Search Results

1

Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model.

Inoue Y, Toga K, Sudo T, Tachibana K, Tochizawa S, Kimura Y, Yoshida Y, Hidaka H. Inoue Y, et al. Among authors: sudo t. Br J Pharmacol. 2000 May;130(2):231-41. doi: 10.1038/sj.bjp.0703287. Br J Pharmacol. 2000. PMID: 10807659 Free PMC article.

2

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H. Sudo T, et al. Biochem Pharmacol. 2000 Feb 15;59(4):347-56. doi: 10.1016/s0006-2952(99)00346-9. Biochem Pharmacol. 2000. PMID: 10644042

3

Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.

Sudo T, Ito H, Ozeki Y, Kimura Y. Sudo T, et al. Br J Pharmacol. 2001 Aug;133(8):1396-404. doi: 10.1038/sj.bjp.0704204. Br J Pharmacol. 2001. PMID: 11498527 Free PMC article.

4

Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats.

Tani T, Uehara K, Sudo T, Marukawa K, Yasuda Y, Kimura Y. Tani T, et al. Among authors: sudo t. Atherosclerosis. 2000 Oct;152(2):299-305. doi: 10.1016/s0021-9150(99)00480-3. Atherosclerosis. 2000. PMID: 10998457

5

Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method.

Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, Kimura Y. Ozeki Y, et al. Among authors: sudo t. Thromb Res. 2001 Jan 15;101(2):65-72. doi: 10.1016/s0049-3848(00)00377-7. Thromb Res. 2001. PMID: 11342207

6

[Annexin family].

Hidaka H, Sudo T. Hidaka H, et al. Among authors: sudo t. Tanpakushitsu Kakusan Koso. 1998 Sep;43(12 Suppl):1652-8. Tanpakushitsu Kakusan Koso. 1998. PMID: 9788165 Review. Japanese. No abstract available.

7

Cyclic AMP specific phosphodiesterase activity and colon cancer cell motility.

Murata K, Sudo T, Kameyama M, Fukuoka H, Muka M, Doki Y, Sasaki Y, Ishikawa O, Kimura Y, Imaoka S. Murata K, et al. Among authors: sudo t. Clin Exp Metastasis. 2000;18(7):599-604. doi: 10.1023/a:1011926116777. Clin Exp Metastasis. 2000. PMID: 11688965

8

Regulation of calcyclin (S100A6) binding by alternative splicing in the N-terminal regulatory domain of annexin XI isoforms.

Sudo T, Hidaka H. Sudo T, et al. J Biol Chem. 1998 Mar 13;273(11):6351-7. doi: 10.1074/jbc.273.11.6351. J Biol Chem. 1998. PMID: 9497364 Free article.

9

Characterization of the calcyclin (S100A6) binding site of annexin XI-A by site-directed mutagenesis.

Sudo T, Hidaka H. Sudo T, et al. FEBS Lett. 1999 Feb 5;444(1):11-4. doi: 10.1016/s0014-5793(99)00014-9. FEBS Lett. 1999. PMID: 10037139 Free article.

10

Isoform-specific intracellular vesicle formation by recombinant annexin XI-A in Sf9 cells.

Sudo T, Mamiya N, Goto M, Watanabe Y, Hidaka H. Sudo T, et al. Biochem Biophys Res Commun. 1996 Jun 25;223(3):706-11. doi: 10.1006/bbrc.1996.0967. Biochem Biophys Res Commun. 1996. PMID: 8687461

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

768 results

Search Page

Filters